OPERF
LGND icon

Oregon Public Employees Retirement Fund’s Ligand Pharmaceuticals LGND Stock Holding History

Oregon Public Employees Retirement Fund’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.45M Buy
4,579
+79
+2% +$18.6K 0.02% 739
2026
Q1 		$898K Buy
4,500
+15
+0.3% +$2.97K 0.01% 895
2025
Q4 		$848K Buy
4,485
+43
+1% +$8.26K 0.01% 937
2025
Q3 		$787K Hold
4,442
– – 0.01% 961
2025
Q2 		$505K Buy
4,442
+100
+2% +$10.7K 0.01% 1111
2025
Q1 		$457K Sell
4,342
-100
-2% -$11.3K 0.01% 1143
2024
Q4 		$476K Buy
4,442
+132
+3% +$14.9K 0.01% 1177
2024
Q3 		$431K Buy
4,310
+200
+5% +$20.1K 0.01% 1205
2024
Q2 		$346K Sell
4,110
-300
-7% -$23.9K 0.01% 1250
2024
Q1 		$322K Sell
4,410
-388
-8% -$28.6K 0.01% 1301
2023
Q4 		$343K Sell
4,798
-30
-0.6% -$1.77K 0.01% 1335
2023
Q3 		$289K Sell
4,828
-300
-6% -$19.7K ﹤0.01% 1472
2023
Q2 		$370K Hold
5,128
– – ﹤0.01% 1418
2023
Q1 		$377K Sell
5,128
-210
-4% -$14.9K ﹤0.01% 1400
2022
Q4 		$357K Sell
5,338
-3,200
-37% -$208K ﹤0.01% 1428
2022
Q3 		$459K Sell
8,538
-335
-4% -$19.7K 0.01% 1295
2022
Q2 		$494K Sell
8,873
-1,165
-12% -$66.1K 0.01% 1129
2022
Q1 		$704K Sell
10,038
-321
-3% -$23.3K 0.01% 1256
2021
Q4 		$998K Sell
10,359
-480
-4% -$44.3K 0.01% 1011
2021
Q3 		$942K Buy
10,839
+1,760
+19% +$136K 0.01% 1031
2021
Q2 		$743K Buy
9,079
+500
+6% +$41.6K 0.01% 1173
2021
Q1 		$816K Hold
8,579
– – 0.01% 1113
2020
Q4 		$532K Sell
8,579
-404
-4% -$23K 0.01% 1215
2020
Q3 		$534K Sell
8,983
-829
-8% -$56.6K 0.01% 1085
2020
Q2 		$685K Sell
9,812
-733
-7% -$46.5K 0.01% 969
2020
Q1 		$478K Sell
10,545
-2,133
-17% -$121K 0.01% 1044
2019
Q4 		$825K Sell
12,678
-1,388
-10% -$92.8K 0.01% 989
2019
Q3 		$873K Buy
14,066
+248
+2% +$15.6K 0.01% 1018
2019
Q2 		$984K Buy
13,818
+188
+1% +$13.8K 0.01% 971
2019
Q1 		$1.07M Buy
13,630
+147
+1% +$11.1K 0.02% 910
2018
Q4 		$1.14M Buy
+13,483
New +$1.44M 0.02% 826

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oregon Public Employees Retirement Fund's LGND Position: Q2 2026 in Review

Oregon Public Employees Retirement Fund increased its Ligand Pharmaceuticals (LGND) stake by 1.8% in Q2 2026, buying an estimated $18.6K and bringing the position to 4,579 shares worth $1.45M. The position accounts for 0.02% of the portfolio, ranked #739.

Oregon Public Employees Retirement Fund first reported a position in LGND in Q4 2018 and has held it in 31 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Oregon Public Employees Retirement Fund held 4,579 shares of Ligand Pharmaceuticals worth $1.45M as of Q2 2026.
  • Oregon Public Employees Retirement Fund bought 79 Ligand Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
  • Ligand Pharmaceuticals made up 0.02% of Oregon Public Employees Retirement Fund's portfolio in Q2 2026, its #739 holding.
  • Oregon Public Employees Retirement Fund first reported a position in Ligand Pharmaceuticals in Q4 2018 and has held it in 31 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Oregon Public Employees Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.